Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parvovirus vectors for human gene therapy.

A Srivastava1

  • 1Department of Microbiology & Immunology, Walther Oncology Center, Indiana University School of Medicine, Indianapolis 46202-512, USA. asrivast@iupui.edu

Current Opinion in Molecular Therapeutics
|November 9, 2001
PubMed
Summary

Parvovirus vectors show promise as safe alternatives for gene therapy, proving effective in clinical trials for cystic fibrosis and hemophilia B. Their unique features suggest broad potential for treating various human diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dengue virus infection in renal allograft recipients: a case series during 2010 outbreak.

Transplant infectious disease : an official journal of the Transplantation Society·2012
Same author

Metal-insulator transition in SrTiO(3-x) thin films induced by frozen-out carriers.

Physical review letters·2011
Same author

Disruption of a mitochondrial protease machinery in Plasmodium falciparum is an intrinsic signal for parasite cell death.

Cell death & disease·2011
Same author

Social interaction and neuroses (the family and the primary group): a pilot study.

Indian journal of psychiatry·2011
Same author

Indigenous therapy in practice of psychiatry in India.

Indian journal of psychiatry·2011
Same author

The relation between depression and parkin genotype: the CORE-PD study.

Parkinsonism & related disorders·2011

Area of Science:

  • Gene therapy
  • Viral vector technology
  • Molecular medicine

Background:

  • Retroviral and adenoviral vectors are commonly used in gene therapy.
  • Parvovirus-based vectors offer potential advantages over traditional vectors.
  • Clinical applications of viral vectors are expanding.

Purpose of the Study:

  • To evaluate the safety and utility of parvovirus-based vectors.
  • To highlight the potential of parvovirus vectors in human disease gene therapy.
  • To support the growing use of parvovirus vectors in clinical settings.

Main Methods:

  • Review of existing clinical trial data.
  • Analysis of parvovirus vector characteristics.
  • Comparison with retroviral and adenoviral vector systems.

Main Results:

  • Parvovirus vectors demonstrated safety and utility in Phase I clinical trials.
  • Successful application in gene therapy for cystic fibrosis and hemophilia B.
  • Identification of key features supporting broader therapeutic applications.

Conclusions:

  • Parvovirus-based vectors are a safe and effective alternative for gene therapy.
  • Their successful clinical trial outcomes justify further investigation for diverse diseases.
  • The imminent use of parvovirus vectors in treating human diseases is well-supported.

Related Experiment Videos